Charlotte, NCNCT06527872Now EnrollingIRB Ready

Lupus Nephritis Clinical Trial in Charlotte, NC

Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Charlotte. Study-provided care at no cost to qualified participants.

Sponsored by GlaxoSmithKline

Quick Self-Assessment

See if you qualify for this Charlotte location

Preparing your pre-screening questions…

Expert Care in Charlotte

Access lupus nephritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lupus nephritis treatment provided free

Apply for This Charlotte Location

Check if you qualify for this lupus nephritis clinical trial in Charlotte, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Charlotte

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Charlotte site if eligible
  4. 4Begin participation

About This Lupus Nephritis Study in Charlotte

The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest. This study aims to provide the first long-term (up to 5 years) assessment of renal function preservation in belimumab treated participants.

Sponsor: GlaxoSmithKline

Who Can Participate

Inclusion Criteria

Participants to provide a signed informed consent at the time of enrollment per protocol,
Male or female aged 18 or over at initiation of belimumab,
Participants received belimumab in any formulation (subcutaneous or intravenous) for the treatment of active LN prescribed as per local label in combination with standard immunosuppressive therapy/ies at initiation of belimumab,
Participants initiated belimumab 6 to 24 months prior to study enrollment,
Accessibility of medical records starting at belimumab initiation (including accessibility of medical records for the prior 12 months and confirmatory biopsy at any time prior to belimumab initiation),
Biopsy-confirmed LN diagnosis at any time prior to belimumab initiation for treatment of LN
Class III (focal LN) with or without Class V (membranous LN),
Class IV (diffuse LN) with or without Class V,

Exclusion Criteria

Participants receiving renal replacement therapy (i.e., dialysis, kidney transplant, or those in end-stage kidney disease) at initiation of belimumab,
Participant is concomitantly receiving another SLE targeted monoclonal antibody (MAb), or a MAb expected to compromise immune responses, at initiation of belimumab,
Participants in a clinical trial during the observation period (with the exception of allowing participation in other non-interventional studies),
Participant is pregnant at the initiation of belimumab,
Participant with a kidney transplant at the initiation of belimumab,
Participants will be excluded from the study if they are planning to become pregnant or are pregnant at study enrollment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Charlotte?

Yes, this clinical trial (NCT06527872) has an active research site in Charlotte, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lupus Nephritis Treatment Options in Charlotte, NC

If you're searching for lupus nephritis treatment options in Charlotte, NC, this clinical trial (NCT06527872) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Charlotte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lupus nephritis clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Charlotte, NC

See all lupus clinical trials recruiting in Charlotte — not just this study.

Browse Lupus Trials in Charlotte →

Browse More Trials by Condition

Lupus TrialsPulmonary Hypertension TrialsSystemic Lupus Erythematosus TrialsLupus Nephritis TrialsAll Conditions →

Ready to Join in Charlotte?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Charlotte, NC